[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Michelle Solly [@MSollender](/creator/twitter/MSollender) on x 13.1K followers Created: 2025-07-22 20:12:22 UTC $ABVX Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis XXXXXX engagements  **Related Topics** [$abvx](/topic/$abvx) [Post Link](https://x.com/MSollender/status/1947751594671673714)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Michelle Solly @MSollender on x 13.1K followers
Created: 2025-07-22 20:12:22 UTC
$ABVX Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
XXXXXX engagements
Related Topics $abvx
/post/tweet::1947751594671673714